SEC Form SC 13G filed by Guardian Pharmacy Services Inc.
$GRDN
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/21/2024 | $21.00 | Outperform | Raymond James |
| 10/21/2024 | $22.00 | Buy | Truist |
424B4 - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
EFFECT - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
S-1 - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the pricing of the previously announced underwritten public offering (the "Offering") of 7,500,000 shares of its Class A common stock, at a public offering price of $21.00 per share, of which 6,059,553 shares will be sold by certain selling stockholders and 1,440,447 shares will be issued and sold by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of Class A common stock at the public offering price, less the underwriting discount. The Offering i
Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the launch of a proposed underwritten public offering (the "Offering") of 7,500,000 shares of its Class A common stock, consisting of 6,059,553 shares being offered by certain selling stockholders and 1,440,447 newly issued shares being offered by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders intend to grant the underwriters a 30‑day option to purchase up to an additional 1,125,000 shares of Class A common stock at the public offering price, less the underwriting discount. The proposed Offering is considered non-dilutive as Guardian int
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced the acquisition of Senior Care Pharmacy in Wichita, Kan. The acquisition expands Guardian's operations into south central and southwest Kansas, strengthening its overall presence across the state and enabling it to bring its high-quality pharmacy services to residents in assisted living, skilled nursing and behavioral health communities, as well as individuals with intellectual and developmental disabilities in these newly served areas. With the addition of the Wichita location, Guardian now operates two pharmacies in Kansas – Kansa
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced the acquisition of Senior Care Pharmacy in Wichita, Kan. The acquisition expands Guardian's operations into south central and southwest Kansas, strengthening its overall presence across the state and enabling it to bring its high-quality pharmacy services to residents in assisted living, skilled nursing and behavioral health communities, as well as individuals with intellectual and developmental disabilities in these newly served areas. With the addition of the Wichita location, Guardian now operates two pharmacies in Kansas – Kansa
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its first quarter 2025 results on Monday, May 12, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "96083." A replay will be available shortly after the call's completion and remain available for approximately 60 days
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (800) 245-3047 for U.S. participants, or (203) 518-9765 for international participants, and referencing conference ID "Guardian." A replay will be available shortly after the call's completion and remain available for approximately 60
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)
SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)
SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)
Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif
Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent
Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00
Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00